Structure-Based Design of Potent, Selective, and Orally Bioavailable VPS34 Kinase Inhibitors
- Research Organization:
- Advanced Photon Source (APS), Argonne National Laboratory (ANL), Argonne, IL (US)
- Sponsoring Organization:
- DOE - Office Of Science; INDUSTRY
- OSTI ID:
- 1900949
- Journal Information:
- J. Med. Chem., Journal Name: J. Med. Chem. Journal Issue: (17) Vol. 65
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Discovery of chiral dihydropyridopyrimidinones as potent, selective and orally bioavailable inhibitors of AKT
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Lo
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
Journal Article
·
Fri Jun 01 00:00:00 EDT 2018
· Bioorganic and Medicinal Chemistry Letters
·
OSTI ID:1474162
Structure-Based Design of Active-Site-Directed, Highly Potent, Selective, and Orally Bioavailable Lo
Journal Article
·
Sat Oct 01 00:00:00 EDT 2022
· J. Med. Chem.
·
OSTI ID:1901192
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor
Journal Article
·
Mon Sep 16 00:00:00 EDT 2024
· Journal of Medicinal Chemistry
·
OSTI ID:2581513